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ABSTRACT
Stool samples from patients with abdominal symptoms were used to evaluate different copro-diagnostic
assays for the detection of Giardia and Cryptosporidium. Results from microscopical examination
following conventional stool concentration and direct ﬂuorescent-antibody methods were compared
with various commercially available immunochromatographic and enzyme immunoassays. Of 220
samples, 45 were positive for Giardia and 17 for Cryptosporidium. For Giardia, the sensitivities obtained by
Ridascreen Giardia, Rida Quick Giardia, Rida Quick Combi and Giardia-Strip were 82%, 80%, 80% and
44%, respectively. For Cryptosporidium, the sensitivities obtained by Rida Quick Cryptosporidium,
Ridascreen Cryptosporidium, Rida Quick Combi and Cryptosporidium-Strip were 88%, 82%, 82% and
75%, respectively. The speciﬁcity of all tests was ‡ 98%. Other intestinal parasites were present in 68
samples, but cross-reactions with other protozoan or helminthic parasites were not observed. Overall,
the copro-antigen assays were less time-consuming and easier to perform, but were less sensitive than
conventional microscopical methods. Thus, these tests might be a useful addition to, but not a substitute
for microscopical methods in the diagnosis of travel-associated giardiasis and cryptosporidiosis.
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INTRODUCTION
Giardia lamblia and Cryptosporidium spp. are com-
mon protozoan parasites in humans, causing
intestinal infections with watery diarrhoea,
abdominal pain and malabsorption that may last
for weeks to months [1,2]. In travellers, Giardia
lamblia and Cryptosporidium spp. are, together
with Entamoeba histolytica, the most frequent
causes of intestinal protozoan infection [3].
Conventional microscopical diagnosis of Giardia
and Cryptosporidium infections is time-consuming,
and relies crucially on the microscopist’s skills and
experience [4,5]. Furthermore, microscopical
examination must be performed on three stool
samples to increase sensitivity [6], which leads to
problems concerning patient compliance and
delays in the ﬁnal diagnosis. In an attempt to
establish sensitive and cost-effective methods to
diagnose intestinal infections with Giardia and
Cryptosporidium, a number of copro-antigen tests
have been developed [4,7–11]. The aim of the
present study was to compare microscopical tests
with various commercially available copro-anti-
gen assays to detect Giardia and Cryptosporidium
infections in clinical samples from patients
attending an outpatient clinic in Germany specia-
lising in tropical medicine.
MATERIALS AND METHODS
In total, 220 fresh stool specimens were tested at the Diagnostic
Laboratory of the Institute of Tropical Medicine in Berlin,
Germany. The samples were obtained from patients attending
the outpatient clinic of the Institute of Tropical Medicine who
presented with abdominal symptoms, mainly diarrhoea, after
travelling abroad. All specimens were anonymised and pro-
cessed separately to prevent observer bias.
One aliquot of each sample was immediately preserved and
concentrated by the routine merthiolate iodine formaldehyde
concentration (MIFC) method [12]. Concentrated samples were
examined by light microscopy for ova and parasites (O & P)
and by a direct ﬂuorescent-antibody assay (DFA) (MeriFluor
Crypto&Giardia; Meridian Bioscience, Cincinnati, OH, USA).
For DFA, 10 lL of the concentrated specimen was smeared on
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a DFA well slide and allowed to air-dry. Staining was
performed according to the manufacturer’s instructions. If
samples were positive for Cryptosporidium by DFA, the
diagnosis was conﬁrmed by Kinyoun modiﬁed acid-fast
staining, as described previously [13].
A second aliquot of each stool specimen was immediately
frozen and stored at )20C. Subsequently, the frozen aliquots
were thawed and mixed thoroughly before testing with ﬁve
immunochromatographic dipstick tests (ICT): Rida Quick
Giardia; Rida Quick Cryptosporidium; Rida Quick Cryptospori-
dium ⁄Giardia Combi (R-Biopharm, Darmstadt, Germany);
Giardia-Strip; and Cryptosporidium-Strip (Coris BioConcepts,
Gembloux, Belgium). Two enzyme immunoassays (EIAs) were
also evaluated: Ridascreen Giardia and Ridascreen Cryptospor-
idium (R-Biopharm). All seven tests were performed according
to the manufacturers’ instructions.
Samples with discordant results in microscopical (O & P
and DFA) and copro-antigen tests (ICT and EIA) were retested
and additional commercially available tests were applied
(ProSpectT Giardia Microplate Assay and ProSpectT Cryptos-
poridium Microplate Assay; Remel, Lenexa, KS, USA).
Specimens that met one of the following criteria were
considered to be true Giardia positives: (i) O & P-positive and
DFA-positive for Giardia; (ii) DFA and at least one copro-
antigen test positive for Giardia; or (iii) at least four of ﬁve
copro-antigen tests positive for Giardia.
Specimens that met the following criteria were considered
to be true Cryptosporidium positives: (i) DFA-positive for
Cryptosporidium and veriﬁed by Kinyoun stain; or (ii) at least
four of ﬁve copro-antigen tests positive for Cryptosporidium.
RESULTS
Of the 220 stool samples, 45 were conﬁrmed as
true positives for Giardia, and 17 for Cryptospor-
idium. Other intestinal parasites were diagnosed
by microscopy of concentrated specimens in 68
samples: Endolimax nana (n = 30), Entamoeba
histolytica ⁄ dispar (n = 16), Entamoeba coli (n = 14),
Blastocystis hominis (n = 10), Ascaris lumbricoides
(n = 3), Strongyloides stercoralis (n = 3), Trichuris
trichivra (n = 3), Iodamoeba buetschlii (n = 2), Di-
entamoeba fragilis (n = 2), Cyclospora cayetanensis
(n = 2), hook worm (n = 2), Isospora belli (n = 1)
and Entamoeba hartmanni (n = 1).
The results obtained with the different methods
are shown in Table 1. Sensitivity and speciﬁcity,
as well as positive and negative predictive values,
are summarised in Table 2. Results of the differ-
ent detection procedures for Giardia were concor-
dant for 190 samples. Discordant results
(24 samples) were associated mainly with false-
negative reactions in copro-antigen assays. Three
positive Giardia samples were not detected by
microscopical methods (O & P and DFA).
False-positive Giardia results were obtained with
three specimens: one specimen, free of intestinal
parasites, was false-positive by Rida Quick
Giardia and Ridascreen Giardia; a second speci-
men, positive for Cryptosporidium, was false-pos-
itive by Ridascreen Giardia, and a third specimen,
containing Endolimax nana and Dientamoeba fragil-
is, was false-positive by DFA.
For Cryptosporidium, results were discordant for
nine samples. Four samples were false-negative
by at least one copro-antigen assay, while one
sample containing Giardia, and two samples that
were negative for parasites, were false-positive by
Cryptosporidium-Strip. Two samples were false-
negative by DFA.
The Giardia- and Cryptosporidium-Strip assays
yielded invalid test results with two and seven
specimens, respectively, because control lines
were not obtained.
DISCUSSION
All seven commercially available assays were
easy to perform and less time-consuming than
Table 1. Results of various diagnostic procedures for the
detection of Giardia and Cryptosporidium in stool specimens
Giardia Cryptosporidium
True
negative
True
positive
True
negative
True
positive
Number of specimens 45 175 17 203
Number of positive specimens by:
O & P microscopy 41 0 NA NA
DFA Meriﬂuor 42 1 15 0
Rida Quick Giardia 36 1 NA NA
Rida Quick Cryptosporidium NA NA 15 0
Rida Quick Combi 36 0 14 0
Ridascreen Giardia 37 2 NA NA
Ridascreen Cryptosporidium NA NA 14 0
Giardia-Strip 20 0a NA NA
Cryptosporidium-Strip NA NA 12b 3c
NA, not applicable.
aTwo samples with invalid test results.
bOne sample with invalid test result.
cSix samples with invalid test results.
O & P, ova and parasites.
Table 2. Sensitivity, speciﬁcity, positive predictive value
(PPV) and negative predictive value (NPV) of Giardia and
Cryptosporidium stool assays
Genus
and assay
Sensitivity
(%)
Speciﬁcity
(%)
PPV
(%)
NPV
(%)
Giardia
Rida Quick Giardia 80.0 99.4 97.3 95.1
Rida Quick Combi 80.0 100.0 100.0 95.1
Ridascreen Giardia 82.2 98.9 94.9 95.6
Giardia-Strip 44.4 100.0 100.0 87.4
Cryptosporidium
Rida Quick Cryptosporidium 88.2 100.0 100.0 99.0
Rida Quick Combi 82.4 100.0 100.0 98.5
Ridascreen Cryptosporidium 82.4 100.0 100.0 98.5
Cryptosporidium-Strip 75.0 98.5 80.0 98.0
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microscopical examinations. Compared with the
EIA tests, the dipstick kits had the advantage of
being less time-consuming and simpler to carry
out, and did not require an ELISA microplate
reader or other specialised equipment. However,
the Giardia-Strip and the Cryptosporidium-Strip
yielded invalid test results in two (0.9%) and
seven (3.2%) of the tested stool samples, respect-
ively. All of the assays had high speciﬁcity values
(Table 2) and no cross-reactions with other intes-
tinal parasites were observed. False-positive
results with Giardia and Cryptosporidium copro-
antigen tests have been reported previously
[14–16], and the present study generated false-
positive results with the Rida Quick Giardia,
Ridascreen Giardia and Cryptosporidium-Strip
assays. The latter test had a positive predictive
value of 80%, indicating that, apart from epide-
miological surveys, positive results with this
assay should be conﬁrmed microscopically.
For diagnosis of Giardia infections, the Rida
Quick Giardia, Rida Quick Combi and Ridascreen
Giardia assays provided the best results, with
sensitivities ranging from 80.0% to 82.2%. In
contrast, the Giardia-Strip had a sensitivity of only
44.4%. For diagnosis of Cryptosporidium infec-
tions, Rida Quick Cryptosporidium performed best
(sensitivity of 88.2%), followed by Rida Quick
Combi and Ridascreen Cryptosporidium (sensitiv-
ities of 82.4%). The Cryptosporidium-Strip had a
sensitivity of only 75.0%. Sensitivity rates report-
ed previously for various commercially available
immunochromatographic and EIAs detecting
Giardia and ⁄ or Cryptosporidium copro-antigen
range from 63% to 100% [4,7,8,17–21]. Since
different studies evaluating identical assays re-
port diverse sensitivity values, it seems that the
test performances are also inﬂuenced by the study
methodology and data analysis. For example, two
separate evaluations of the ProSpectT Cryptospor-
idium microplate assay reported sensitivity values
of 70% and 100%, respectively [4,19].
A factor complicating the comparison of var-
ious copro-antigen studies is the absence of a true
reference standard. Usually, the reference stand-
ard is based on microscopical pathogen detection,
a method that is impossible to standardise
because it is inﬂuenced signiﬁcantly by the
individual skills of the microscopists involved.
Furthermore, microscopy can be false-negative for
cases with a low parasite density, or when intact
microorganisms are absent. To overcome these
limitations, the reference standard in the present
study was not based entirely on microscopical
methods, but also took into account the results of
the copro-antigen tests. Another important factor
inﬂuencing the performance of copro-antigen
assays is the study population. In the present
study, the specimens examined derived mainly
from adult travellers with a wide range of clinical
symptoms who were suffering from various
stages of infection.
False-negative copro-antigen test results have
been associated with low parasite densities [22].
Patients in the present study were often diag-
nosed at a late stage of infection, at which time
low parasite densities have been reported in
cryptosporidial infections [23], and may also be
found in cases of giardiasis. This could explain
the relatively low sensitivity values of the evalu-
ation as compared with studies using specimens
that derived from outbreaks [4,11] or from im-
munocompromised patients [24]. Unfortunately,
many previous copro-antigen studies have not
provided clinical and epidemiological informa-
tion for the study population examined. In con-
trast to other test kits, all assays evaluated in the
present study required native stool specimens.
The use of native samples, especially when
semisolid or solid, creates the risk of uneven
parasite distribution because samples are difﬁcult
to homogenise and usually contain small num-
bers of parasites [23]. This could also have
contributed to the false-negative results obtained.
The above factors concerning study population
and methods, as well as technical aspects, might
explain why the copro-antigen tests evaluated did
not achieve satisfactory sensitivity values. It was
not possible to conﬁrm the high sensitivities of the
Ridascreen Giardia and Cryptosporidium-Strip as-
says that have been reported previously [8,20]. In
agreement with other copro-antigen detection
studies [4,17], the present data suggest that a
signiﬁcant percentage of Giardia and Cryptospori-
dium infections would have been missed if these
assays had been the sole method of diagnosis.
Therefore, if travel-associated giardiasis or cryp-
tosporidiosis is suspected, these copro-antigen
assays cannot substitute for microscopical meth-
ods. However, the tests might be useful if experi-
enced practitioners of stool microscopy are not
available, or for conﬁrmation purposes, except for
the Giardia-Strip assay, which was of inadequate
sensitivity. Copro-antigen tests might also be
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helpful as an addition to microscopy when only a
single stool sample is available.
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